80 FR 48544 - National Institute on Aging; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 156 (August 13, 2015)

Page Range		48544-48544
FR Document		2015-19946

Federal Register, Volume 80 Issue 156 (Thursday, August 13, 2015)

[Federal Register Volume 80, Number 156 (Thursday, August 13, 2015)]
[Notices]
[Page 48544]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19946]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel; Physiological Studies on Aging.
    Date: September 28, 2015.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Aging, Gateway Building, Suite 
2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Maurizio Grimaldi, Ph.D., MD Scientific Review 
Officer, National Institute on Aging, National Institutes of Health, 
7201 Wisconsin Avenue, Room 2C218, Bethesda, MD 20892, 301-496-9374, 
grimaldim2@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: August 10, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-19946 Filed 8-12-15; 8:45 am]
BILLING CODE 4140-01-P

48544 Federal Register / Vol. 80, No. 156 / Thursday, August 13, 2015 / Notices

individual, to the extent necessary to confidential trade secrets or commercial be required to receive copies of the
assure payment of benefits to which the property such as patentable material, patent applications.
individual is entitled. and personal information concerning SUPPLEMENTARY INFORMATION:
5. Requests by phone. Because individuals associated with the grant Technology descriptions follow.
positive identification of the caller applications, the disclosure of which
cannot be established with sufficient would constitute a clearly unwarranted Rabbit Antisera to Various Matrix,
certainty, telephone requests for access invasion of personal privacy. Matricellular, and Other Secreted
to records will not be honored. Proteins
Name of Committee: National Institute on
6. Accounting of disclosures. An Aging Special Emphasis Panel; Physiological Description of Technology: The
individual who is the subject of records Studies on Aging. extracellular matrix (ECM) is composed
maintained in this records system may Date: September 28, 2015. of a group of proteins that regulate many
also request an accounting of all Time: 12:00 p.m. to 5:00 p.m. cellular functions, such as cell shape,
disclosures outside the Department, if Agenda: To review and evaluate grant adhesion, migration, proliferation, and
any, that have been made from that applications. differentiation. Deregulation of ECM
individual’s records. Place: National Institute on Aging, protein production or function
Gateway Building, Suite 2C212, 7201 contributes to many pathological
CONTESTING RECORD PROCEDURES: Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
conditions, including asthma, chronic
An individual seeking to contest the obstructive pulmonary disease,
content of information about him or her Contact Person: Maurizio Grimaldi, Ph.D.,
MD Scientific Review Officer, National arthrosclerosis, and cancer. Scientists at
in this system should contact the the NIH have developed antisera against
Institute on Aging, National Institutes of
applicable System Manager at the Health, 7201 Wisconsin Avenue, Room various ECM components such as
address specified under ‘‘System 2C218, Bethesda, MD 20892, 301–496–9374, proteoglycan, sialoprotein, collagen, etc.
Manager’’ above and reasonably identify grimaldim2@mail.nih.gov. (http://www.nidcr.nih.gov/Research/
the record, specify the information (Catalogue of Federal Domestic Assistance NIDCRLaboratories/CranioSkeletal/
contested, state the corrective action Program Nos. 93.866, Aging Research, Antisera.htm). These antisera can be
sought, and provide the reasons for the National Institutes of Health, HHS) used as research tools to study the
correction, with supporting justification. Dated: August 10, 2015. biology of extracellular matrix
RECORD SOURCE CATEGORIES: Melanie J. Gray, molecules.
Information is obtained from Program Analyst, Office of Federal Advisory Potential Commercial Applications:
individual personnel members (civilian Committee Policy. Studying the biology of extracellular
employees and Public Health Service [FR Doc. 2015–19946 Filed 8–12–15; 8:45 am] matrix molecules.
officers) and applicants, their Development Stage: Early-stage.
BILLING CODE 4140–01–P
Inventor: Larry Fisher (NIDCR).
dependents and former spouses, Intellectual Property: HHS Reference
governmental and private training No. E–135–2008/0—Research Tool.
facilities, health professional licensing DEPARTMENT OF HEALTH AND
Patent protection is not being pursued
and credentialing organizations (e.g., HUMAN SERVICES
for this technology.
organizations that verify license and Licensing Contact: Sally Hu, Ph.D.,
credential information), government National Institutes of Health
M.B.A.; 301–435–5606; hus@
officials and employees, and from mail.nih.gov
Government-Owned Inventions;
records contained in or transferred from Collaborative Research Opportunity:
Availability for Licensing
predecessor payroll systems. The National Institute for Dental and
AGENCY: National Institutes of Health, Craniofacial Research is seeking
EXEMPTIONS CLAIMED FOR THIS SYSTEM:
HHS. statements of capability or interest from
None.
ACTION: Notice. parties interested in collaborative
Dated: July 30, 2015. research to further develop, evaluate or
John W. Gill, SUMMARY: The inventions listed below commercialize antibodies for studying
Deputy Assistant Secretary, ASA. are owned by an agency of the U.S. the biology of extracellular matrix
[FR Doc. 2015–19855 Filed 8–12–15; 8:45 am] Government and are available for molecules. For collaboration
BILLING CODE 4151–17–P
licensing in the U.S. in accordance with opportunities, please contact David
35 U.S.C. 209 and 37 CFR part 404 to Bradley, Ph.D. at bradleyda@
achieve expeditious commercialization nidcr.nih.gov.
DEPARTMENT OF HEALTH AND of results of federally-funded research
HUMAN SERVICES and development. Foreign patent mNFHcre Transgenic Mice
applications are filed on selected Description of Technology: Knockout
National Institutes of Health inventions to extend market coverage mouse is a valuable model to study
for companies and may also be available biological functions of target genes.
National Institute on Aging; Notice of for licensing. When Cre expressing mice are bred with
Closed Meeting FOR FURTHER INFORMATION CONTACT: mice containing a loxP-flanked gene, the
Pursuant to section 10(d) of the Licensing information and copies of the gene between the loxP sites will be
Federal Advisory Committee Act, as U.S. patent applications listed below deleted in the offsprings. Scientists at
amended (5 U.S.C. App.), notice is may be obtained by writing to the the NIH have generated mNF–H-cre
tkelley on DSK3SPTVN1PROD with NOTICES

hereby given of the following meeting. indicated licensing contact at the Office transgenic mouse lines that express Cre
The meeting will be closed to the of Technology Transfer, National recombinase under the control of the
public in accordance with the Institutes of Health, 6011 Executive promoter of the neurofilament-H gene,
provisions set forth in sections Boulevard, Suite 325, Rockville, which is expressed in the late stage of
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Maryland 20852–3804; telephone: 301– neuronal maturation. The transgenic
as amended. The grant applications and 496–7057; fax: 301–402–0220. A signed mice express cre in neurons (but not
the discussions could disclose Confidential Disclosure Agreement will astrocytes) with highest expression in

VerDate Sep<11>2014 16:56 Aug 12, 2015 Jkt 235001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\13AUN1.SGM 13AUN1

Document Created: 2018-02-23 10:56:59
Document Modified: 2018-02-23 10:56:59

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 28, 2015.
FR Citation		80 FR 48544

80 FR 48544 - National Institute on Aging; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 156 (August 13, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health